go-v.orgdoi

Development and Validation of a Nomogram to Predict the Benefit of Adjuvant Radiotherapy for Patients with Resected Gastric Cancer

Shuqiang Yuan, Wen-jing Wu, Miao‐Zhen Qiu, Zixian Wang, Lu-Ping Yang, Ying Jin, Jing‐Ping Yun, Yuan-Hong Gao, Yuhong Li, Zhi-Wei Zhou, Feng Wang, Rui‐Hua Xu · Journal of Cancer · 2017

  • DOI 10.7150/jca.19879
  • Publisher Ivyspring International Publisher
  • Type article
  • Issued 2017

Not cached yet. This record was fetched live for this request and is stored after the lookup. Reopening the page should serve the cached copy.

Journal of Cancer · Ivyspring International Publisher · article · 2017

Abstract

Background: The US guidelines for gastric cancer (GC) recommend adjuvant radiotherapy (ART) combined with 5-fluorouracil as a standard treatment for patients with resected locally advanced GC.However, patient selection criteria for optimizing the use of adjuvant therapies are lacking.In this study, we developed and validated a nomogram to predict the individualized overall survival (OS) benefit of ART among patients with resected ≥stage IB GC.

Patients and Methods:The 2002-2006 Surveillance, Epidemiology, and End Results (SEER) data of 5,206 patients with resected GC were used as a training set for the development of a nomogram.The 2007-2008 SEER data of 1,986 patients with resected GC were used as validation data.

Results:In the multivariate analysis weighted by inverse propensity score, the efficacy of ART varied by the ratio of positive to examined nodes (Pinteraction<0.01).The magnitude of this difference was included in the nomogram with associated prognosticators to predict the 3-and 5-year OS with and without ART.The nomogram showed significant prognostic superiority to the 8 th TNM staging in the training set (Concordance index, 0.68 versus 0.65; P<0.01) and the validation set (Concordance index, 0.68 versus 0.64; P<0.01).Moreover, the calibration was accurate, and the actual efficacy of ART was positively correlated with the nomogram-estimated survival benefit from ART (Pinteraction<0.01 and Pinteraction=0.02 in the training set and the validation set, respectively).Conclusion: The nomogram can aid individualized clinical decision making by estimating the 3and 5-year OS and potential benefits of ART among patients with resected GC.

Open the resolved locator · 10.7150/jca.19879

Metadata licence: OpenAlex metadata (CC0)

Registry
OpenAlex DOI index + API
Fetched
2026-11-19 21:26 UTC
Cache state
not cached yet (bulk-index+openalex)
Locator
https://www.jcancer.org/v08p3498.htm
Metadata licence
OpenAlex metadata (CC0)
Scope
Metadata as returned by the resolver; abstracts are never generated here.